• Home
  • About
    • About EIPG
    • The Statute
    • Bureau and Executive
      • The Past Presidents Advisory Committee
    • Member States
    • EIPG Awards
      • EIPG Award Recipients
  • Information
    • Guides and Codes
    • Position Papers
  • Education
  • Media Library
    • Presentations
    • Photo Gallery
  • News
    • From the Bureau
    • News from EIPG
    • News from our Member Associations
    • Business & Policies
    • EU Focus
    • Regulatory Affairs
    • Sustainability & Environment
    • Technology & Research
  • Members
    • Members Area
    • Webinars
  • Contact Us
Login Area

Members Area

 

Follow Us
Facebook
Twitter
LinkedIn
YouTube
Slideshare
EIPG Logo
  • Home
  • About
    • About EIPG
    • The Statute
    • Bureau and Executive
      • The Past Presidents Advisory Committee
    • Member States
    • EIPG Awards
      • EIPG Award Recipients
  • Information
    • Guides and Codes
    • Position Papers
  • Education
  • Media Library
    • Presentations
    • Photo Gallery
  • News
    • From the Bureau
    • News from EIPG
    • News from our Member Associations
    • Business & Policies
    • EU Focus
    • Regulatory Affairs
    • Sustainability & Environment
    • Technology & Research
  • Members
    • Members Area
    • Webinars
  • Contact Us

EIPG Feedback on proposed GMP Guidelines

The European Commission recently launched a public consultation on a Commission Delegated Act on principles and guidelines on good manufacturing practice for investigational medicinal products and on inspection procedures, pursuant to the first subparagraph of Article 63(1) of Regulation (EU) No 536/2014 and Detailed Commission guidelines on good manufacturing practice for investigational medicinal products for human use, pursuant to the second subparagraph of Article 63(1) of Regulation (EU) No 536/2014. EIPG has reviewed the documents and. following feedback from its members, has submitted its comments on the Commission.

Read the EIPG Feedback on the proposed Commission Delegated Act and GMP Guidelines.

  • The first report on the implementation of the HTA regulation
    • March 23, 2026
  • ACT EU Multi-Stakeholder Platform Annual Meeting 2025
    • March 9, 2026
  • Tabletting Technology Course 2026 | Royal Pharmaceutical Society
    • March 6, 2026
  • IDAP, the IFPMA’s vision of innovation development and access pathways
    • February 27, 2026
  • 2026 trends in pharmaceutical development
    • February 12, 2026
  • Many advancements in the setting up of the new pharmaceutical legislation
    • January 26, 2026
  • Bacteriophages and AMR, the beginning of a new era?
    • December 10, 2025
  • The EU Commission adopted the rules for JCAs of medical devices and in vitro diagnostics
    • November 25, 2025
  • The UK’s new decentralised manufacturing framework
    • November 6, 2025
  • The challenging roadmap to design the future of EU’s R&D
    • October 13, 2025
EU Transparency Register
EIPG is registered in the EU
Transparency Register with public ID
number 979567925318-36

0
0
0
32
0
Disclaimer and Privacy Policy
  • Privacy Policy
  • Disclaimer
Contacts
  • General Inquiries
  • President
  • Executive Director
  • Vice-President Communications
  • News from our Member Associations